Urology Doctors in Du Bois, PA Accepting Medicare

4 Urology doctors found. Showing 1 - 4

Mr. Indraneel Banerjee, M.D. Urology Medicare: Medicare Enrolled Practice Location: 145 Hospital Ave Ste 200, Du Bois, PA 15801 Phone: 814-375-9200    Fax: 814-375-9080

Dr. John Samuel Banerji, MD, M.CH Urology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Ave, Du Bois, PA 15801 Phone: 814-371-2200

Assodolah Assadnia, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 145 Hospital Ave, Suite 313, Du Bois, PA 15801 Phone: 814-375-9200    Fax: 814-375-9980

Dr. Joseph E Chang, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 145 Hospital Ave, Suite 200, Du Bois, PA 15801 Phone: 814-375-9200    Fax: 814-375-9980

News Archive

Manduka announces the debut of eQua Hot Yoga Towel

Manduka (www.manduka.com), the world's leader in high performance yoga gear, announced today the debut of the eQua Hot Yoga Towel—the newest addition to the Manduka eQua Towel Collection. For those that prefer their yoga hot, the eQua Hot Yoga Towel is the ultimate solution to sweat management—allowing the user to perfect their poses instead of dealing with a perspiring distraction from their practice.

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

St James's Institute of Oncology orders two Versa HD systems to improve patient care

St James's Institute of Oncology, a leading radiotherapy center in the UK, recently ordered two Versa HD™ systems, an advanced linear accelerator designed to improve patient care and treat a wide range of tumors throughout the body.

FDA approves Pfizer's Geodon Capsules for the adjunctive maintenance treatment of bipolar disorder

Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder.

Read more Medical News

› Verified 6 days ago